Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Japan Bio Science Laboratory (JBSL) is a specialized biotechnology company focused on the research, development, and manufacturing of functional food ingredients and bio-active compounds. The company is globally recognized as the pioneer of Nattokinase, specifically its proprietary NSK-SD brand, which is a potent fibrinolytic enzyme derived from fermented soybeans. Beyond cardiovascular health, JBSL develops specialized extracts such as Ashitaba (containing unique chalcones) and sesame lignans targeted at metabolic and liver health. Headquartered in Osaka, Japan, with a significant international presence, the company provides clinically-backed ingredients to the pharmaceutical and nutraceutical industries. JBSL maintains a strong emphasis on fermentation technology and rigorous safety standards, including non-vitamin K2 certification for its flagship enzyme products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Japan Bio.